RankingsPricing
  1. US-listed companies
  2. ALNYLAM PHARMACEUTICALS, INC.
  3. Financials
  4. Return on equity (%)

ALNYLAM PHARMACEUTICALS, INC.【ALNY】

Market cap
$51.9B
P/E ratio
SummaryFinancials
Period EndReturn on equity (%) (Million USD)YoY (%)
Dec 31, 2022-526.1+394.91%
Dec 31, 2021-106.3+52.05%
Dec 31, 2020-69.9+8.13%
Dec 31, 2019-64.7+30.28%
Dec 31, 2018-49.6+35.82%
Dec 31, 2017-36.5-2.66%
Dec 31, 2016-37.5+42.41%
Dec 31, 2015-26.4-55.88%
Dec 31, 2014-59.7+35.37%
Dec 31, 2013-44.1-47.54%
Dec 31, 2012-84.1+101.53%
Dec 31, 2011-41.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)